Skip to content
healthcare.dev
Get a free key

DEFERASIROX

NDC 31722-029, DEFERASIROX, granule, from Camber Pharmaceuticals, Inc..

Product NDC
31722-029
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216229
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX90 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
31722-029-323172200293230 PACKET in 1 CARTON (31722-029-32) / 1 GRANULE in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eded6687-ba78-4117-a316-eec56d46a08a

Use it

Look up 31722-029 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.